ACCESS was initially conceptualized, developed, and refined in an open clinical trial as part of the College STAR project (Supporting Transition Access Retention), funded by the Oak Foundation, GlaxoSmithKline, and a consortium of private foundations in Greensboro, NC. Under the direction of Dr. Arthur D. Anastopoulos (Principal Investigator, UNC Greensboro) and Dr. Joshua M. Langberg (Co-Principal Investigator, Virginia Commonwealth University), our research team recently completed a comprehensive examination of the benefits of ACCESS in the context of a four-year, randomized controlled trial study, funded by the Institute of Education Sciences (IES) in the U.S. Department of Education. Findings from both trials lend strong support to its efficacy. To assist others interested in implementing ACCESS, we have created a treatment manual, developed training videos, and published our findings in research journals.